simvastatin has been researched along with Graft vs Host Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Fang, J; Hong, M; Li, BB; Nie, DM; Wu, QL; Xia, LH; Zhang, R; Zheng, P | 1 |
| Brandl, U; Detter, C; Kreuzer, E; Kur, F; Mair, H; Meiser, BM; Seidel, D; Thiery, J; Uberfuhr, P; Wenke, K | 1 |
1 trial(s) available for simvastatin and Graft vs Host Disease
| Article | Year |
|---|---|
Prevention and treatment of graft vessel disease after heart transplantation.
Topics: Adult; Arteriosclerosis; Blood Component Removal; Cholesterol; Double-Blind Method; Female; Graft Occlusion, Vascular; Graft vs Host Disease; Heart Transplantation; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Oligopeptides; Peptides, Cyclic; Prospective Studies; Risk Factors; Simvastatin; Somatostatin; Tissue Donors | 1995 |
1 other study(ies) available for simvastatin and Graft vs Host Disease
| Article | Year |
|---|---|
Simvastatin ameliorates graft-vs-host disease by regulating angiopoietin-1 and angiopoietin-2 in a murine model.
Topics: Angiopoietin-1; Angiopoietin-2; Animals; Aorta; Disease Models, Animal; Endothelial Cells; Gene Expression; Graft vs Host Disease; Mice; Simvastatin | 2017 |